Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Journal of Cancer Survivorship
Published in: Journal of Cancer Survivorship 6/2022

21-09-2021 | Correction

Correction to: Preventive service utilization among low‑income cancer survivors

Authors: Brenna E. Blackburn, Miguel Marino, Teresa Schmidt, John Heintzman, Brigit Hatch, Jennifer DeVoe, Laura Moreno, Nathalie Huguet

Published in: Journal of Cancer Survivorship | Issue 6/2022

Login to get access

Excerpt

Correction to: Journal of Cancer Survivorship …
Metadata
Title
Correction to: Preventive service utilization among low‑income cancer survivors
Authors
Brenna E. Blackburn
Miguel Marino
Teresa Schmidt
John Heintzman
Brigit Hatch
Jennifer DeVoe
Laura Moreno
Nathalie Huguet
Publication date
21-09-2021
Publisher
Springer US
Published in
Journal of Cancer Survivorship / Issue 6/2022
Print ISSN: 1932-2259
Electronic ISSN: 1932-2267
DOI
https://doi.org/10.1007/s11764-021-01108-5

Other articles of this Issue 6/2022

Journal of Cancer Survivorship 6/2022 Go to the issue

OriginalPaper

Determinants of sleep quality in 5835 individuals living with and beyond breast, prostate, and colorectal cancer: a cross-sectional survey

OriginalPaper

Disparities in healthcare utilization and access by length of cancer survivorship among population-based female cancer survivors

Review

Strategies to self-manage side-effects of adjuvant endocrine therapy among breast cancer survivors: an umbrella review of empirical evidence and clinical guidelines

Review

Large-scale North American cancer survivorship surveys: 2011–2019 update

Correction

Correction to: Sensory signs and symptoms in women with self-reported breast cancer–related lymphedema: a case–control study

OriginalPaper

Predicting physical activity change in cancer survivors: an application of the Health Action Process Approach
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits